McLaren agrees to $7.75 million settlement on opioid drug diversion charges
McLaren agrees to $7.75 million settlement on opioid drug diversion charges Print McLaren Health Care Corp., a 14-hospital health system based in Grand Blanc, has agreed to a $7.75 million civil settlement over the health system's handling of controlled substances in its retail pharmacy program, federal officials said Tuesday. The settlement resolved allegations that McLaren violated certain provisions of the federal Controlled Substances Act, according to a statement from U.S. attorneys Andrew Birge in the Western Michigan District and Matthew Schneider in the Eastern Michigan District. It e...